Latest Articles

Publication Date
ESSE Care Aims to Transform Endometriosis Care by Launching a Year-Long Initiative That Brings Together Patients and Experts Worldwide - ACCESS Newswire

ESSE Care Aims to Transform Endometriosis Care by Launching a Year-Long Initiative That Brings Together Patients and Experts Worldwide ACCESS Newswire

Published: March 19, 2025, 12:02 p.m.
NHS approval of endometriosis therapy Ryeqo enhances patient care - The Hippocratic Post

NHS approval of endometriosis therapy Ryeqo enhances patient care The Hippocratic Post

Published: March 19, 2025, 12:01 p.m.
ESSE Care Aims to Transform Endometriosis Care by Launching a Year-Long Initiative That Brings Together Patients and Experts Worldwide - Newswire

ESSE Care Aims to Transform Endometriosis Care by Launching a Year-Long Initiative That Brings Together Patients and Experts Worldwide Newswire

Published: March 19, 2025, noon
Lightbulb moment that led to Ruth Scott's endometriosis diagnosis - EVOKE

Lightbulb moment that led to Ruth Scott's endometriosis diagnosis EVOKE

Published: March 19, 2025, 11:38 a.m.
Better endometriosis treatments may lie in migraine medications - Boston Children's Discoveries

Better endometriosis treatments may lie in migraine medications Boston Children's Discoveries

Published: March 19, 2025, 11:30 a.m.
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - Weekly Voice

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy Weekly Voice

Published: March 19, 2025, 11:20 a.m.
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - Yahoo Canada Finance

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy Yahoo Canada …

Published: March 19, 2025, 11 a.m.
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - Yahoo Finance

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy Yahoo Finance

Published: March 19, 2025, 11 a.m.
What Is Endometriosis And What Are It's Symptoms Specially In Teenagers? Know From An Expert - Jagran English

What Is Endometriosis And What Are It's Symptoms Specially In Teenagers? Know From An Expert Jagran English

Published: March 19, 2025, 10 a.m.
GP reveals seven ways to relieve endometriosis symptoms - News-Medical.Net

GP reveals seven ways to relieve endometriosis symptoms News-Medical.Net

Published: March 19, 2025, 9:54 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!